Oregon State University researchers have developed a breakthrough iron-based nanomaterial that destroys cancer cells from within while sparing healthy tissue. The material, created by Oleh Taratula, Olena Taratula, and Chao Wang, triggers two simultaneous chemical reactions inside tumor cells, overwhelming them with oxidative stress.

This innovation advances chemodynamic therapy (CDT), which exploits the unique acidic environment and elevated hydrogen peroxide levels found in tumors. Traditional CDT approaches generate either hydroxyl radicals or singlet oxygen, but not both. The new iron-based metal-organic framework overcomes this limitation by producing both reactive oxygen species, dramatically increasing its cancer-fighting potential.

In preclinical trials, the nanomaterial completely eradicated tumors in mice with human breast cancer cells without causing adverse effects. Tumors disappeared entirely and did not return, while the animals showed no signs of systemic toxicity. The researchers plan to test the treatment across additional cancer types, including aggressive pancreatic cancer, before advancing to human trials.